Datametrex Appoints Paul Haber as Director and Insider Exercising Options and Warrants Emerging Technology Investing
Codebase Investment Adds Oral Mucosal Patent Filing, Expanding Transdermal Treatments Pharmaceutical Investing
Datametrex Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program Emerging Technology Investing
InsuraGuest Now Licensed to Sell Insurance in 47 US States, Including California and Florida Fintech Investing
Datametrex Provides Update On Health Canada Submission & Welcomes Advisors Emerging Technology Investing
Hydroxychloroquine Side Effects Potentially Mitigated by Transdermal Delivery Pharmaceutical Investing
Codebase Ventures: Hydroxychloroquine Treatment for COVID-19 Benefits Sought in Global Research Effort to Establish Efficacy Blockchain Investing
Codebase Ventures Inc. Announces $1.5 Million Financing and First Closing of Financing Fintech Investing
Datametrex Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea Emerging Technology Investing
